The anteriorly based partial thickness sternocleidomastoid (SCM) muscle flap is among the various methods described to correct parotidectomy defects, but its indications and limitations are not clearly demonstrated in several reports. This study was done to test the aesthetic outcome of this method, its indications and limitations. At Dr. Babasaheb Ambedkar Memorial hospital, Mumbai, 20 patients presenting with benign parotid tumors underwent parotidectomy. 16 underwent superficial parotidectomy and 3 underwent adequate parotidectomy, 1 had total parotidectomy. The anteriorly based partial thickness SCM muscle flap was used to correct the contour deformity and to prevent Frey syndrome. The aesthetic result was evaluated by assessing and scoring the overall appearance of the scar, the degree of symmetry of the reconstructed parotid region and the site of the donor muscle in comparison to their contralateral normal sides. The overall aesthetic appearance was good in 17 patients, and moderate in 3 patients. 17/20 patients had an overall deep satisfaction with the result. The residual hollowness following total parotidectomy defect and the poor quality of scars were the main reasons affecting the aesthetic outcome. Superficial parotidectomy through modified Blair's incision with immediate reconstruction with anteriorly based partial thickness SCM flap allows a satisfactory aesthetic outcome and minimal donor site morbidity. Scores of the above two parameters were accessed. Patients' satisfaction was assessed by patients questionnaire.
<p>Non-Hodgkin lymphoma is a type of hematologic malignancy derived from lymphocytes, which varies significantly in their severity, from slow growing to very aggressive types. Incidence increases with age. Up to 45 years of age Non-Hodgkin lymphoma is more common among males than females. Various etiological factors includes infectious agents like Epstein-barr virus, Human T-cell leukemia virus, Helicobacter pylori, Human herpes virus-8, Hepatitis c virus, HIV etc. Exposure to chemical like polychlorinated biphenyls, phenoxy herbicides and medical treatments like radiation therapy and chemotherapy also act as etiological factors. Genetic diseases like Klinefelter’s syndrome, ataxia telangiectasia and autoimmune diseases like celiac sprue, rheumatoid arthritis and systemic lupus erythematosus can also act as causal factors. NHL in nose and nasal cavity is a rare finding. Ours is a case series of two rare case of non-Hodgkin lymphoma presented with a nasal mass with nasal obstruction. The first case is a sixty years old female patient who presented with a right nasal mass with nasal obstruction. The second case is a fifty years old male who presented with left side nasal mass with left proptosis. We diagnosed these cases by taking biopsy from the nasal masses. These cases highlighted the importance of good clinical history and examination along with management according to definite protocols in regarding to avoid missing a rare.</p>
<p>Thyroglossal duct cyst is a congenital lesion in the anterior side of neck which results from embryonic remnant of the descending thyroglossal duct. It may get enlarge by infection, inflammation or mucous retention but can be found anywhere in the midline from the base of the tongue to thyroid gland. Most commonly it is present infrahyoid only. In this case, it is present at an unusual site at suprasternal region. A young male presented in the OPD with a single, non-tender swelling in the midline at suprasternal region, almost reaching upto superior mediastinum. After radiological examination and histopathological excision biopsy, it came out to be thyroglossal cyst. No recurrence had occurred.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.